Latest Cutter Capital Management, LP Stock Portfolio
Cutter Capital Management, LP Performance:
2024 Q3: 6.49%YTD: 5.11%
Performance for 2024 Q3 is 6.49%, and YTD is 5.11%.
About Cutter Capital Management, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Cutter Capital Management, LP reported an equity portfolio of $338.8 Millions as of 30 Sep, 2024.
The top stock holdings of Cutter Capital Management, LP are GILD, BMY, RPRX. The fund has invested 8.9% of it's portfolio in GILEAD SCIENCES INC and 8.8% of portfolio in BRISTOL-MYERS SQUIBB CO.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), MERCK & CO INC (MRK) and AMGEN INC (AMGN) stocks. They significantly reduced their stock positions in BIOCRYST PHARMACEUTICALS INC (BCRX), ARCELLX INC (ACLX) and AVADEL PHARMACEUTICALS PLC. Cutter Capital Management, LP opened new stock positions in BRISTOL-MYERS SQUIBB CO (BMY), AGILENT TECHNOLOGIES INC (A) and ELI LILLY & CO (LLY). The fund showed a lot of confidence in some stocks as they added substantially to PERRIGO CO PLC (PRGO), HARMONY BIOSCIENCES HLDGS IN (HRMY) and BRIDGEBIO PHARMA INC (BBIO).
The top stock holdings of Cutter Capital Management, LP are GILD, BMY, RPRX. The fund has invested 8.9% of it's portfolio in GILEAD SCIENCES INC and 8.8% of portfolio in BRISTOL-MYERS SQUIBB CO.
The fund managers got completely rid off BIOMARIN PHARMACEUTICAL INC (BMRN), MERCK & CO INC (MRK) and AMGEN INC (AMGN) stocks. They significantly reduced their stock positions in BIOCRYST PHARMACEUTICALS INC (BCRX), ARCELLX INC (ACLX) and AVADEL PHARMACEUTICALS PLC. Cutter Capital Management, LP opened new stock positions in BRISTOL-MYERS SQUIBB CO (BMY), AGILENT TECHNOLOGIES INC (A) and ELI LILLY & CO (LLY). The fund showed a lot of confidence in some stocks as they added substantially to PERRIGO CO PLC (PRGO), HARMONY BIOSCIENCES HLDGS IN (HRMY) and BRIDGEBIO PHARMA INC (BBIO).
Cutter Capital Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Cutter Capital Management, LP made a return of 6.49% in the last quarter. In trailing 12 months, it's portfolio return was 18.57%.
New Buys
| Ticker | $ Bought |
|---|---|
| bristol-myers squibb co | 29,701,700 |
| agilent technologies inc | 17,889,600 |
| eli lilly & co | 15,325,900 |
| regeneron pharmaceuticals | 15,217,800 |
| jazz pharmaceuticals plc | 13,090,700 |
| springworks therapeutics inc | 12,125,600 |
| viridian therapeutics inc | 11,799,900 |
| axsome therapeutics inc | 9,505,280 |
New stocks bought by Cutter Capital Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| perrigo co plc | 457 |
| harmony biosciences hldgs in | 27.23 |
| bridgebio pharma inc | 27.17 |
| gilead sciences inc | 22.55 |
Additions to existing portfolio by Cutter Capital Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| biocryst pharmaceuticals inc | -59.59 |
| arcellx inc | -51.94 |
| avadel pharmaceuticals plc | -47.45 |
| ionis pharmaceuticals inc | -39.25 |
| vera therapeutics inc | -24.84 |
| ultragenyx pharmaceutical in | -21.42 |
| enliven therapeutics inc | -6.77 |
| sarepta therapeutics inc | -6.29 |
Cutter Capital Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| kenvue inc | -17,460,100 |
| teva pharmaceutical inds ltd | -14,818,400 |
| evolus inc | -5,048,500 |
| avantor inc | -8,480,000 |
| biomarin pharmaceutical inc | -22,520,000 |
| cytokinetics inc | -12,835,200 |
| crispr therapeutics ag | -10,882,900 |
| pfizer inc | -5,181,900 |
Cutter Capital Management, LP got rid off the above stocks
Sector Distribution
Cutter Capital Management, LP has about 92.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 92.3 |
| Others | 7.7 |
Market Cap. Distribution
Cutter Capital Management, LP has about 45.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 40.7 |
| MID-CAP | 37.3 |
| SMALL-CAP | 9.7 |
| UNALLOCATED | 7.7 |
| MEGA-CAP | 4.5 |
Stocks belong to which Index?
About 69.5% of the stocks held by Cutter Capital Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 37.6 |
| S&P 500 | 31.9 |
| Others | 30.4 |
Cutter Capital Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Cutter Capital Management, LP
Cutter Capital Management, LP has 27 stocks in it's portfolio. About 56% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. RARE was the most profitable stock for Cutter Capital Management, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 5.28 | 120,485 | 17,889,600 | new | |||
| ACLX | arcellx inc | 2.21 | 89,863 | 7,504,460 | reduced | -51.94 | ||
| AGIO | agios pharmaceuticals inc | 2.45 | 186,623 | 8,291,660 | new | |||
| AMGN | amgen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTR | avantor inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 2.81 | 105,767 | 9,505,280 | new | |||
| BBIO | bridgebio pharma inc | 2.98 | 396,388 | 10,092,000 | added | 27.17 | ||
| BCRX | biocryst pharmaceuticals inc | 1.79 | 798,137 | 6,065,840 | reduced | -59.59 | ||
| BIIB | biogen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMY | bristol-myers squibb co | 8.77 | 574,057 | 29,701,700 | new | |||
| CRSP | crispr therapeutics ag | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EOLS | evolus inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GILD | gilead sciences inc | 8.88 | 359,025 | 30,100,700 | added | 22.55 | ||
| HRMY | harmony biosciences hldgs in | 4.44 | 376,315 | 15,052,600 | added | 27.23 | ||
| INSM | insmed inc | 4.65 | 215,884 | 15,759,500 | reduced | -5.16 | ||
| IONS | ionis pharmaceuticals inc | 1.15 | 97,300 | 3,897,840 | reduced | -39.25 | ||
| IOVA | iovance biotherapeutics inc | 2.43 | 876,009 | 8,225,720 | new | |||
| JAZZ | jazz pharmaceuticals plc | 3.86 | 117,500 | 13,090,700 | new | |||